PubMed for id: 349942

Year	Number of Results
1993	1
1995	1
1999	1
2002	1
2003	2
2005	3
2006	4
2015	1
2016	1
2024	0

1

Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological Activity.

Novakova Z, Wozniak K, Jancarik A, Rais R, Wu Y, Pavlicek J, Ferraris D, Havlinova B, Ptacek J, Vavra J, Hin N, Rojas C, Majer P, Slusher BS, Tsukamoto T, Barinka C. Novakova Z, et al. J Med Chem. 2016 May 26;59(10):4539-50. doi: 10.1021/acs.jmedchem.5b01806. Epub 2016 Apr 25. J Med Chem. 2016. PMID: 27074627

2

Structural and biochemical characterization of a novel aminopeptidase from human intestine.

Tykvart J, Bařinka C, Svoboda M, Navrátil V, Souček R, Hubálek M, Hradilek M, Šácha P, Lubkowski J, Konvalinka J. Tykvart J, et al. J Biol Chem. 2015 May 1;290(18):11321-36. doi: 10.1074/jbc.M114.628149. Epub 2015 Mar 9. J Biol Chem. 2015. PMID: 25752612 Free PMC article.

3

Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction.

Conway RE, Petrovic N, Li Z, Heston W, Wu D, Shapiro LH. Conway RE, et al. Mol Cell Biol. 2006 Jul;26(14):5310-24. doi: 10.1128/MCB.00084-06. Mol Cell Biol. 2006. PMID: 16809768 Free PMC article.

4

Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.

Thomas AG, Wozniak KM, Tsukamoto T, Calvin D, Wu Y, Rojas C, Vornov J, Slusher BS. Thomas AG, et al. Adv Exp Med Biol. 2006;576:327-37; discussion 361-3. doi: 10.1007/0-387-30172-0_24. Adv Exp Med Biol. 2006. PMID: 16802724 Review.

5

Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer.

Mesters JR, Barinka C, Li W, Tsukamoto T, Majer P, Slusher BS, Konvalinka J, Hilgenfeld R. Mesters JR, et al. EMBO J. 2006 Mar 22;25(6):1375-84. doi: 10.1038/sj.emboj.7600969. Epub 2006 Feb 9. EMBO J. 2006. PMID: 16467855 Free PMC article.

6

MEROPS: the peptidase database.

Rawlings ND, Morton FR, Barrett AJ. Rawlings ND, et al. Nucleic Acids Res. 2006 Jan 1;34(Database issue):D270-2. doi: 10.1093/nar/gkj089. Nucleic Acids Res. 2006. PMID: 16381862 Free PMC article.

7

Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen.

Slovin SF. Slovin SF. Expert Opin Ther Targets. 2005 Jun;9(3):561-70. doi: 10.1517/14728222.9.3.561. Expert Opin Ther Targets. 2005. PMID: 15948673 Free PMC article. Review.

8

Is prostate-specific membrane antigen a multifunctional protein?

Rajasekaran AK, Anilkumar G, Christiansen JJ. Rajasekaran AK, et al. Am J Physiol Cell Physiol. 2005 May;288(5):C975-81. doi: 10.1152/ajpcell.00506.2004. Am J Physiol Cell Physiol. 2005. PMID: 15840561 Free article. Review.

9

Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase.

Davis MI, Bennett MJ, Thomas LM, Bjorkman PJ. Davis MI, et al. Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):5981-6. doi: 10.1073/pnas.0502101102. Epub 2005 Apr 18. Proc Natl Acad Sci U S A. 2005. PMID: 15837926 Free PMC article.

10

A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen.

Rajasekaran SA, Anilkumar G, Oshima E, Bowie JU, Liu H, Heston W, Bander NH, Rajasekaran AK. Rajasekaran SA, et al. Mol Biol Cell. 2003 Dec;14(12):4835-45. doi: 10.1091/mbc.e02-11-0731. Epub 2003 Oct 3. Mol Biol Cell. 2003. PMID: 14528023 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

15 results

Results by year